Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

Stereotactic Body Radiation Therapy for Lung Cancer a Key Topic for Elekta Presenters at Annual ASTRO Conference

Press releases may be edited for formatting or style | July 20, 2010

The clinicians are affiliated with the University of Wurzburg, The Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital (NKI/AvL), Princess Margaret Hospital / University Health Network, Thomas Jefferson University Hospital and William Beaumont Hospital.

Advanced Elekta SBRT technology used today includes Elekta Axesse™ and Elekta Synergy® S treatment systems and Symmetry™ and Intuity™ software. Symmetry is a breakthrough technology that enables highly accurate, yet completely non-invasive lung tumor treatments without requiring additional intra-fraction radiation imaging. Intuity ensures that not only is the tumor's position accounted for, but also the position of nearby healthy critical structures. Both innovations contribute to a more patient-friendly and safe treatment.

stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats

(1)Retrieved June 29, 2010 from the Cancer Monthly website: http://www.cancermonthly.com/cancer_basics/lung.asp

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

Back to HCB News